AKTX — Akari Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $7.84m
- $4.00m
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 20-F | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 5.73 | 14.1 | 9.36 | 13.2 | 3.85 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6.44 | 14.6 | 11.6 | 13.8 | 4.34 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.005 | 0 | — | — | — |
Net Intangible Assets | |||||
Total Assets | 6.48 | 14.6 | 11.6 | 13.8 | 4.36 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.47 | 5.22 | 6.09 | 12 | 4.58 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 6.47 | 5.22 | 6.09 | 12 | 4.58 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.008 | 9.38 | 5.55 | 1.79 | -0.229 |
Total Liabilities & Shareholders' Equity | 6.48 | 14.6 | 11.6 | 13.8 | 4.36 |
Total Common Shares Outstanding |